Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2025-12-25 @ 5:26 PM
NCT ID:
NCT02187003
Group ID:
EG000
Title:
Rivipansel Treatment Arm
Description:
Participants with sickle cell disease (SCD) received intravenous (IV) infusion of rivipansel while hospitalized for treatment of a vaso-occlusive crisis (VOC). Participants aged \>=12 years, with body weight \>40 kilogram (kg) received a loading dose of 1680 milligram (mg) rivipansel on Day 1 followed by maintenance doses of 840 mg rivipansel administered at 12 hourly intervals.
Participants aged 6 to 11 years or any participant weighing \<=40 kg received a loading dose of 40 milligram per kilogram body weight (mg/kg) rivipansel on Day 1 (maximum of 1680 mg) followed by maintenance doses of 20 mg/kg rivipansel (maximum of 840 mg) administered at 12 hourly intervals. Participants received rivipansel until they met the protocol-defined criteria for readiness-for-discharge from hospital or up to a maximum of 15 doses (1 loading dose and 14 maintenance doses), whichever occurred first. Dosing therefore continued for a maximum of 8 days.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
52
Serious Number At Risk:
162
Other Number Affected:
137
Other Number At Risk:
162
Study:
NCT02187003
Results Section:
NCT02187003
Adverse Events Module:
NCT02187003